SPX -0.58% VIX 4.38%
WAR OF WILL WINS 144TH PREAKNESS IN RACE THAT INCLUDED RIDERLESS HORSE
MICHIGAN GOP CONGRESSMAN SEEN AS FIRST OF PARTY TO SAY TRUMP ACTS IMPEACHABLE
AOC STANDS WITH BUFFETT: CEO NET WORTH SHOULD TAKE A HIT IF BAILOUT GIVEN
JOE BIDEN PITCHES HIMSELF AS A UNITER EVEN AS HE TEARS INTO TRUMP
HERE'S THE STOCK PLAY BOOSTED BY 'GAME OF THRONES' BANDWIDTH HOGS
THE TARIFF TIFF AND A FED RETHINK ARE JUST TWO AREAS OF STOCK-MARKET ANGST
ECONOMIC PREVIEW: CONSUMER SPENDING SLOWS, INVESTMENT HURT BY CHINA TRADE WAR
STRATEGIST: A NUMBER OF INDICATORS SUGGEST THE STOCK MARKET COULD EXTEND GAINS
AUSTRALIAS RULING CONSERVATIVE COALITION APPEARS HEADED TO A SURPRISE WIN
U.S. STOCKS END LOWER FOR DAY AND WEEK ON U.S.-CHINA TRADE UNCERTAINTY
Sun, May 19 9:27am



Name PRICE MARKET CAPITALIZATION PRICE TO EARNINGS RATIO DIVIDEND YIELD SYMBOL EXCHANGE PRICE PERCENT DIFFERENCE YEAR TO DATE PRICE PERCENT DIFFERENCE 5 YEAR CHART 1 YEAR CHART

Amgen Inc [AMGN]
$169.91 0.01 (0.01%)

AMGN Profile

Sector Health Care
Industry Biotech & Pharma
Market Cap 103.64 Billion
AMGN Description

Amgen is a leader in biotechnology-based human therapeutics, with historical expertise in renal disease and cancer supportive care products. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and received approval for bone-strengthening drug Prolia/Xgeva in 2010. Amgen's acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Nexavar and Kyprolis. Recent launches include Repatha (cholesterol-lowering) and Aimovig (migraine).


Visit Website

AMGN Earnings

EPS 3.20 P/E Ratio 15.15
Previous Earnings Tue, Jan 29, 2019
Latest Earnings Tue, Apr 30, 2019 (19 days ago)

AMGN Dividend

Yield 3.41% / $5.80
Ex-Date Thu, May 16, 2019 (3 days ago)
Pay Date Fri, Jun 7, 2019
History 32 Payments (Quarterly)

AMGN Charts

$167.60
52 Week Range
$208.89
May 13, 2019
Sep 27, 2018

169.91 103.64 15.15 3.41 AMGN NASDAQ -0.01 -11.46 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=AMGN&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=AMGN&exchange=NASDAQ&chart=1

Symbol Price % YTD
AMGN $169.91 -0.01% -11.46%


Symbol Surfing

How can we make Symbol Surfing better?

info@symbolsurfing.com

Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.



©2019 Symbol Surfing All Rights Reserved.

Cookies Policy | Terms Of Service | Privacy Policy